ECC 2015

✓

クレーム

Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA Prof Brastianos talks to ecancertv at ECC 2015 about how unravelling the genetic sequences of cancer that has spread to the brain could offer unexpected targets for treatment. In the interview she highlights the results of a …

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden Prof Naredi talks to ecancertv at ECC 2015 about the use of surgery in synchronous oligometastatic disease. In the interview he highlights that two to three decades ago it was rare that patients with metastatic disease would be refe…

Prof Riccardo Audisio - President of the European Society for Surgical Oncology Prof Audisio talks to ecancertv at ECC 2015 about optimising education about cancer surgery and the need to improve current standards as only 25% of patients receive adequate surgical care. He also talks about the tre…

Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel, Germany Prof Schrappe talks to ecancertv at ECC 2015 about improving both the cure rate and the quality of life for survivors of childhood cancers over the next ten years, with the ultimate aim of increasing disease-free an…

Prof Noel Clarke and Dr Bertrand Tombal Prof Noel Clarke (The Christie Hospital, Manchester, UK) and Dr Bertrand Tombal (Saint-Luc Hospital, Brussels, Belgium) discuss the evolving treatment landscape in prostate cancer for ecancertv at ECC 2015, with a particular focus on new data and dialogue ar…

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden Dr Naredi, Scientific Chair of the ECC 2015 meeting, gives his highlights. Including comment on: Cabozantinib improves survival in patients with advanced kidney cancer: results from the METEOR trial Nivolumab improves overall survi…

Prof Gilles Vassal - University Paris-Sud, Orsay, France Prof Vassal talks to ecancertv at ECC 2015 about research looking at expanding patient access to crizotinib and the work of the AcSé Program initiated by the French National Cancer Institute. Crizotinib is currently only approved for use in…

Prof Gilles Vassal - University Paris-Sud, Orsay, France Prof Vassal talks to ecancertv at ECC 2015 about the 'SIOPE strategic plan' working along side the European Community of Paediatric Haematology Oncology to improve both the cure rate and the quality of life for survivors of childhood cancers…

Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA Dr Carducci talks to ecancertv at ECC 2015 about a phase3, randomised, double­-blind, placebo­ controlled study of tasquinimod (TASQ) in men with metastatic castrate resistant prostate cancer (mCRPC).